美国 · SEC FORM 4
Emergent BioSolutions Inc.
EBS · NYSE · CIK 0001367644 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
30 同一窗口内观察到的 Form 4 交易行
10 sales · 20 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 10 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-05-13 · PAPA JOSEPH C.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 9,293,986
- 上期报告
- 9,786,380
- 日均成交量
- 1,119,034
- 回补天数
- 8.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
59 transaction lines in the latest 365-day window; 465 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | DeGolyer Donald W | 卖出 (S) | Common Stock | 17,800 | USD 7.09 | USD 126,202 | SEC 申报 ↗ |
| 2026-10-01 | Williams Paul Anthony | 卖出 (S) | Common Stock | 3,000 | USD 6.53 | USD 19,590 | SEC 申报 ↗ |
| 2026-07-01 | Williams Paul Anthony | 卖出 (S) | Common Stock | 3,000 | USD 8.40 | USD 25,200 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | DeGolyer Donald W | 卖出 (S) | Common Stock | 17,800 | USD 7.09 | USD 126,202 | SEC 申报 ↗ |
| 2026-10-01 | Williams Paul Anthony | 卖出 (S) | Common Stock | 3,000 | USD 6.53 | USD 19,590 | SEC 申报 ↗ |
| 2026-07-01 | Williams Paul Anthony | 卖出 (S) | Common Stock | 3,000 | USD 8.40 | USD 25,200 | SEC 申报 ↗ |
| 2026-06-08 | Williams Paul Anthony | 代扣税 (F) | Common Stock | 694 | USD 8.00 | USD 5,552 | SEC 申报 ↗ |
| 2026-06-08 | LINDAHL RICHARD S | 代扣税 (F) | Common Stock | 3,964 | USD 8.00 | USD 31,712 | SEC 申报 ↗ |
| 2026-06-08 | Hartzel William | 代扣税 (F) | Common Stock | 1,741 | USD 8.00 | USD 13,928 | SEC 申报 ↗ |
| 2026-06-08 | Glessner Coleen | 代扣税 (F) | Common Stock | 2,018 | USD 8.00 | USD 16,144 | SEC 申报 ↗ |
| 2026-05-01 | Zoon Kathryn C | 卖出 (S) | Common Stock | 17,202 | USD 8.40 | USD 144,453 | SEC 申报 ↗ |
| 2026-05-01 | DeGolyer Donald W | 卖出 (S) | Common Stock | 15,481 | USD 8.40 | USD 129,994 | SEC 申报 ↗ |
| 2026-05-01 | Dayal Sujata Tyagi | 卖出 (S) | Common Stock | 13,761 | USD 8.40 | USD 115,610 | SEC 申报 ↗ |
| 2026-04-30 | Zoon Kathryn C | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | White Marvin L | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | Richard Ronald | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | Katkin Keith | 卖出 (S) | Common Stock | 15,481 | USD 8.28 | USD 128,183 | SEC 申报 ↗ |
| 2026-04-30 | Katkin Keith | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | Harsanyi Zsolt | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | Fowler Neal Franklin | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | FOWLER JOHN D JR | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | DeGolyer Donald W | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-30 | Dayal Sujata Tyagi | 奖励／授予 (A) | Common Stock | 25,344 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | Williams Paul Anthony | 奖励／授予 (A) | Common Stock | 100,111 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | Perl Jessica | 奖励／授予 (A) | Common Stock | 104,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | PAPA JOSEPH C | 奖励／授予 (A) | Common Stock | 187,708 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | Lowry Simon C | 奖励／授予 (A) | Common Stock | 100,111 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | LINDAHL RICHARD S | 奖励／授予 (A) | Common Stock | 162,680 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | Hartzel William | 奖励／授予 (A) | Common Stock | 100,111 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-29 | Glessner Coleen | 奖励／授予 (A) | Common Stock | 100,111 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Williams Paul Anthony | 卖出 (S) | Common Stock | 4,000 | USD 8.44 | USD 33,760 | SEC 申报 ↗ |
| 2026-03-05 | Williams Paul Anthony | 代扣税 (F) | Common Stock | 9,397 | USD 8.44 | USD 79,311 | SEC 申报 ↗ |
| 2026-03-05 | Perl Jessica | 代扣税 (F) | Common Stock | 6,465 | USD 8.44 | USD 54,565 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | EBS |
| CIK | 0001367644 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 465 transaction lines from 2020-01-16 to 2026-10-07 2 P purchase lines · 103 S sale lines · 360 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.